Endogenous Production of TGF-β Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-κB Ligand and Macrophage-Colony- Stimulating Factor1
Endogenous Production of TGF-β Is Essential for Osteoclastogenesis Induced by a Combination of Receptor Activator of NF-κB Ligand and Macrophage-Colony- Stimulating Factor1
复制标题
TGF-β 的内源生成对于 NF-κB 配体受体激活剂和巨噬细胞集落刺激因子 1 组合诱导的破骨细胞生成至关重要
作者:
T. Kaneda;T. Nojima;M. Nakagawa;A. Ogasawara;H. Kaneko;Takuya Sato;H. Mano;M. Kumegawa;Y. Hakeda
Differentiation of osteoclasts, the cells primarily responsible for bone resorption, is controlled by a variety of osteotropic hormones and cytokines. Of these factors, receptor activator of NF-κB (RANK) ligand (RANKL) has been recently cloned as an essential inducer of osteoclastogenesis in the presence of M-CSF. Here, we isolated a stroma-free population of monocyte/macrophage (M/Mφ)-like hemopoietic cells from mouse unfractionated bone cells that were capable of differentiating into mature osteoclasts by treatment with soluble RANKL (sRANKL) and M-CSF. However, the efficiency of osteoclast formation was low, suggesting the requirement for additional factors. The isolated M/Mφ-like hemopoietic cells expressed TGF-β and type I and II receptors of TGF-β. Therefore, we examined the effect of TGF-β on osteoclastogenesis. TGF-β with a combination of sRANKL and M-CSF promoted the differentiation of nearly all M/Mφ-like hemopoietic cells into cells of the osteoclast lineage. Neutralizing anti-TGF-β Ab abrogated the osteoclast generation. These TGF-β effects were also observed in cultures of unfractionated bone cells, and anti-TGF-β blocked the stimulatory effect of 1,25-dihydroxyvitamin D3. Translocation of NF-κB into nuclei induced by sRANKL in TGF-β-pretreated M/Mφ-like hemopoietic cells was greater than that in untreated cells, whereas TGF-β did not up-regulate the expression of RANK, the receptor of RANKL. Our findings suggest that TGF-β is an essential autocrine factor for osteoclastogenesis.
登录
查看更多内容
DOI:
10.1210/endo.138.11.5495
发表时间:
1997
期刊:
Endocrinology.
影响因子:
--
作者:
Pilbeam,C;Rao,Y;Voznesensky,O;Kawaguchi,H;Alander,C;Raisz,L;Herschman,H
通讯作者:
Herschman,H
DOI:
10.1073/pnas.85.15.5683
发表时间:
1988-08-01
影响因子:
11.1
作者:
CHENU, C;PFEILSCHIFTER, J;ROODMAN, GD
通讯作者:
ROODMAN, GD
DOI:
--
发表时间:
1998-04
期刊:
The American journal of pathology
影响因子:
--
作者:
E. Gravallese;Y. Harada;Jeng-Tzang Wang;A. Gorn;T. Thornhill;S. Goldring
通讯作者:
E. Gravallese;Y. Harada;Jeng-Tzang Wang;A. Gorn;T. Thornhill;S. Goldring
影响因子:
20.3
作者:
J. Cashman;A. Eaves;E. Raines;R. Ross;C. Eaves
通讯作者:
J. Cashman;A. Eaves;E. Raines;R. Ross;C. Eaves
DOI:
10.1172/jci113647
发表时间:
1988
期刊:
The Journal of clinical investigation
影响因子:
--
作者:
Pfeilschifter,J;Seyedin,SM;Mundy,GR
通讯作者:
Mundy,GR